Behind the Bell: Cytek Biosciences

Published

Cytek Biosciences Chairman & CEO Wenbin Jiang speaks to the company’s mission, why they chose Nasdaq as their partner and how they are changing the cytometry industry.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now